1
|
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
Blood
|
2011
|
2.02
|
2
|
BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
|
Blood
|
2008
|
1.78
|
3
|
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases.
|
Blood
|
2009
|
1.74
|
4
|
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
|
Haematologica
|
2003
|
1.50
|
5
|
Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission.
|
Leuk Lymphoma
|
2007
|
1.41
|
6
|
Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
|
Genes Chromosomes Cancer
|
2011
|
1.17
|
7
|
Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count.
|
Br J Haematol
|
2003
|
1.08
|
8
|
ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
|
Haematologica
|
2011
|
1.08
|
9
|
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
|
Blood
|
2003
|
1.06
|
10
|
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
|
Leuk Lymphoma
|
2011
|
1.01
|
11
|
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
|
Haematologica
|
2006
|
0.98
|
12
|
White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia.
|
Haematologica
|
2010
|
0.98
|
13
|
Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations.
|
Leuk Res
|
2009
|
0.97
|
14
|
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
|
Br J Haematol
|
2005
|
0.94
|
15
|
Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)/TAF15-ZNF384 rearrangement.
|
Leuk Lymphoma
|
2013
|
0.90
|
16
|
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.
|
Blood
|
2005
|
0.87
|
17
|
Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.
|
J Hematol Oncol
|
2014
|
0.87
|
18
|
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
|
Haematologica
|
2008
|
0.87
|
19
|
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
|
Am J Hematol
|
2014
|
0.86
|
20
|
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
|
Br J Haematol
|
2011
|
0.83
|
21
|
An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia.
|
Haematologica
|
2009
|
0.83
|
22
|
Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease.
|
Haematologica
|
2012
|
0.80
|
23
|
Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients.
|
Blood
|
2009
|
0.79
|
24
|
Atypical chronic myeloid leukaemia with CD117-positive blast cells treated with imatinib: A report of two cases.
|
Acta Haematol
|
2006
|
0.79
|
25
|
Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
|
Leuk Res
|
2011
|
0.78
|
26
|
Immunocompetent cell functions in Ph+ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatment.
|
Cancer Immunol Immunother
|
2011
|
0.78
|
27
|
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.
|
Haematologica
|
2002
|
0.77
|
28
|
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.
|
Ann Hematol
|
2014
|
0.77
|
29
|
Is the aberrant expression of p53 by immunocytochemistry a surrogate marker of TP53 mutation and/or deletion in chronic lymphocytic leukemia?
|
Am J Clin Pathol
|
2011
|
0.76
|
30
|
Functional analysis and gene expression profile of umbilical cord blood regulatory T cells.
|
Ann Hematol
|
2011
|
0.76
|
31
|
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.75
|
32
|
Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia.
|
Haematologica
|
2002
|
0.75
|
33
|
Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safety.
|
Acta Haematol
|
2013
|
0.75
|
34
|
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant.
|
Leuk Lymphoma
|
2014
|
0.75
|